Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma
Authors:
Open Access
- 12 June 2024
- journal article
- research article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 25 (1) , 2365449
Abstract
We aimed to evaluate the influence of sirtuin1 (sirt1) on the ESCC chemotherapeutic sensitivity to cisplatin. We used ESCC cell ablation sirt1 for establishing a xenograft mouse tumor model. The tumor volume was then detected. sirt1 was over-expressed significantly in ESCC patients and cells. Moreover, sirt1 knockdown raised ESCC sensitivity to cisplatin. Besides, glycolysis was associated with ESCC cell chemotherapy resistance to cisplatin. Furthermore, sirt1 increased ESCC cells' cisplatin chemosensitivity through HK2. Sirt1 enhanced in vivo ESCC chemosensitivity to cisplatin. Overall, these findings suggested that sirt1 knockdown regulated the glycolysis pathway and raised the ESCC chemotherapeutic sensitivity.Keywords
Funding Information
- the Clinical Research Program of the Air Force Medical University, Key Program (2021LC2103)
- the Xijing Hospital Discipline Boosting Program, Military Medical Clinical Research Program (XJZT21L08)
This publication has 28 references indexed in Scilit:
- Sirtuin activators and inhibitors: Promises, achievements, and challengesPharmacology & Therapeutics, 2018
- Metabolic cooperation between co-cultured lung cancer cells and lung fibroblastsLaboratory Investigation, 2017
- The Warburg Effect and the Hallmarks of CancerAnti-Cancer Agents in Medicinal Chemistry, 2017
- Cisplatin resistance and opportunities for precision medicinePharmacological Research, 2016
- Anticancer Agents Targeted to SirtuinsMolecules, 2014
- Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagyCell Death & Differentiation, 2014
- Cisplatin in cancer therapy: Molecular mechanisms of actionEuropean Journal of Pharmacology, 2014
- Mini-review on Glycolysis and CancerJournal of Cancer Education, 2013
- Subcellular Localization of Hexokinases I and II Directs the Metabolic Fate of GlucosePLOS ONE, 2011
- Esophageal CancerGastroenterology Clinics of North America, 2008